Last reviewed · How we verify
NCT04891926: HODI
Hormonal Influences on Diuresis
NA trial testing ICIQ FLUTS Questionaires in Nocturia in 70 participants. Completed in 30 September 2018.
30 September 2018
Quick facts
| Lead sponsor | University Hospital, Ghent |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 70 |
| Start date | 1 May 2015 |
| Primary completion | 30 September 2018 |
| Estimated completion | 30 September 2018 |
Drugs / interventions tested
- ICIQ FLUTS Questionaires
- Frequency Volume Chart
- Renal Function Profile
- Blood Analysis — full drug profile →
Conditions studied
- Nocturia — all drugs for Nocturia →
- Menopause — all drugs for Menopause →
- LUTS — all drugs for LUTS →
- Diuresis — all drugs for Diuresis →
Sponsor
University Hospital, Ghent
Who can join
40 and older, female only, with Nocturia or Menopause. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study was to observe the effect of hormonal treatment (oral or transdermal substitution therapy) on diuresis (salt and water diuresis) and lower urinary tract symptoms (LUTS) in postmenopausal women
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Does hormonal therapy affect the bladder or the kidney in postmenopausal women with and without nocturnal polyuria: Results of a pilot trial?
Pauwaert K, Bruneel E, Van Laecke E, Depypere H, et al · · 2022 · cited 2× · PMID 35550708 · DOI 10.1016/j.maturitas.2022.01.009
Verify or expand the search:
- PubMed search for NCT04891926
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Nocturia
Currently open trials in the same condition.
- NCT06754189 — Safety and Performance of UCon Patch Electrode · NA · recruiting
- NCT06866834 — Examination of the Effect of Nocturia on Pelvic Floor Symptoms, Sleep Parameters and Quality of Life in Women with Urina · recruiting
- NCT06091566 — Safety and Performance of UCon Bar Electrode for the Treatment of Overactive Bladder (OAB) and Bowel Dysfunction (BD) · NA · recruiting
- NCT05874375 — UCon Treatment of Overactive Bladder (OAB) in Males · NA · recruiting
- NCT05604222 — Effect of Behavioral Sleep Intervention on Lower Urinary Tract Symptoms in Older Women · Phase 4 · recruiting
Other University Hospital, Ghent trials
Trials by the same sponsor.
- NCT07584486 — Development of a New Simplified Tool to Predict LNPCPs Histology and Assess the Risk of Submucosal Invasive Cancer. The · NA · not yet recruiting
- NCT07327450 — Coaching Doctors and Nurses to Improve Ethical Decision-making in Team · NA · not yet recruiting
- NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
- NCT07387328 — Validation of New sEMG Electrode Placement Guidelines for the Triceps Surae in Post-stroke Individuals. · not yet recruiting
- NCT07237399 — Percutaneous Thermo-ablation for the Treatment of Prostate Cancer Oligometastatasis (TA-P-OLIM) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04891926 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Ghent
- Last refreshed: 19 May 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04891926.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing